- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06917391
The Young Adults' Experiences With Virtual Reality (YAES VR) Study
April 20, 2026 updated by: NYU Langone Health
The purpose of this study is to test the effect of virtual reality (VR) food marketing exposure (versus VR non-food control) on snack consumption, purchase intention, hunger, and arousal in black and white young adults.
Participants will be randomized to either the VR food marketing condition or VR non-food control.
Study participation duration will be 2 hours during a one-time, single visit.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Food marketing has been unequivocally linked to poor diet and risk of excessive weight gain in young people.
Food companies disproportionately target Black consumers with more advertisements ("ads") and the least healthy ads, contributing to nutritional disparities and nutrition-related diseases.
To expand their reach, food companies have developed virtual reality (VR) marketing experiences that are engaging, highly sophisticated, and may more powerfully elicit biological signals precipitating a motivation to consume foods.
Yet, little is known about how exposure to VR food marketing influences biological and behavioral outcomes among Black young adults.
The interactional role of food/nutrition insecurity and exposure to VR food marketing among Black young adults is also unknown.
There is a critical need to understand the biological and behavioral effects of VR food marketing among Black communities while the technology is in its infancy.
Study Type
Interventional
Enrollment (Estimated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Omni Cassidy, Ph.D.
- Phone Number: 646-501-3546
- Email: Omni.cassidy@nyulangone.org
Study Contact Backup
- Name: M. Gabriela Valverde
- Phone Number: 646-501-3546
- Email: Maria.valverde@nylangone.org
Study Locations
-
-
New York
-
New York, New York, United States, 10016
- Recruiting
- NYU Langone Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 18-24 years old;
- self-identify as Black or white in order to determine racial/ethnic differences in responses to unhealthy VR-based food and beverage marketing;
- self-report normal or corrected-to-normal vision from glasses or contacts;
- self-report comfort and ability to walk around within a VR paradigm;
- able to read, write, understand, and respond to all study materials (including the VR paradigm) in English
- residing in the NYC-metropolitan area in order to be available for in-person study
- capacity and willingness to provide consent
Exclusion Criteria:
- report a history of disorders causing motion sickness or have a history of significant motion sickness, which could be triggered within the VR paradigm
- self-report dietary restriction, such as food allergies or veganism, which may lead to different effects when exposed to food marketing;
- Self-report disliking 50% or more of the snacks that will be offered during the laboratory test snack as determined by a score of 5 or less on the food preferences questionnaire, which may have a confounding effect on consumption;
- report being pregnant or breastfeeding, which may affect hunger;
- smoke or consume tobacco, which decreases salivary flow; or
- self-report being very hungry based on 100 mm VAS hunger rating, which minimizes the burden to participants to fast prior to the visit and maximizes the ability to detect differences between groups.Those excluded for being very hungry will have the option of returning to the visit on a different day.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Virtual Reality (VR) food marketing exposure
Participants will be given 15 minutes to explore the VR experience and provide feedback on whether they believe their peers would engage with the experience (concealment/deception).
|
In the Wendyverse VR application ("app") participants can order from a Wendy's restaurant, play games, meet with others who may be visiting the Wendyverse, and access codes that can be used to obtain free food at physical restaurants.
|
|
Active Comparator: VR non-food control
Participants will be given 15 minutes to explore the VR experience and provide feedback on whether they believe their peers would engage with the experience (concealment/deception).
|
In Nikeland VR app, participants can play sports, try on apparel, and engage with celebrity athletes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Snack consumption
Time Frame: Post-VR exposure (up to 20 minutes)
|
Following the VR exposure, snacks (health and unhealthy snacks) will be offered to participants with the instruction to eat ad libitum for 20 minutes.
Snack consumption will be measured using a Cardinal Detecto stainless steel scale which transmits weight information wirelessly.
|
Post-VR exposure (up to 20 minutes)
|
|
Purchase intention via self-report questionnaire
Time Frame: Post-VR exposure (~5-10 minutes)
|
Purchase intention will be assessed using a self-report questionnaire.
Questions include: How likely are you to buy food from any fast-food restaurant in the next 2 weeks?
Scores will range from 0 ("Not at all") to 5 ("Highly likely").
Higher scores indicate a higher likelihood to purchase food from the restaurant.
|
Post-VR exposure (~5-10 minutes)
|
|
Change in salivary flow
Time Frame: Baseline, post-VR exposure (~5-10 minutes)
|
A dental roll will be placed horizontally under participants' tongues for 30 seconds pre- and post-VR exposure.
Salivation will not be collected during the exposure so as not to disrupt the immersion.
An increase in salivary flow indicates hunger.
|
Baseline, post-VR exposure (~5-10 minutes)
|
|
Change in electrodermal activity
Time Frame: From baseline to post-VR exposure, up to 15 minutes
|
Electrodermal activity refers to the changes in the electrical properties of the skin due to sweat secretion.
Electrodermal activity is measured through skin conductance, two Ag-AgCl electrodes will be taped to the distal phalanx of the index and ring fingers on the participants' non-dominant hand.
Electrodermal activity will be measured.
A stronger electrodermal response indicates arousal.
|
From baseline to post-VR exposure, up to 15 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Omni Cassidy, Ph.D., NYU Langone Health
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 17, 2025
Primary Completion (Estimated)
March 31, 2028
Study Completion (Estimated)
March 31, 2028
Study Registration Dates
First Submitted
March 25, 2025
First Submitted That Met QC Criteria
March 31, 2025
First Posted (Actual)
April 8, 2025
Study Record Updates
Last Update Posted (Actual)
April 21, 2026
Last Update Submitted That Met QC Criteria
April 20, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- 24-00910
- 1K01MD019320-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices) will be made available as soon as possible or at the time of associated publication.
All data will be shared by the close of the award.
Data will be made available, at minimum, for seven years.
Upon reasonable request The investigator who proposed to use the data.
Data are available for 5 years at a third party website (Open Science Framework: https://osf.io/).
IPD Sharing Time Frame
Data will be made available as soon as possible or at the time of associated publication.
All data to be shared will be shared by the close of the award.
Data will be made available, at minimum, for seven years.
IPD Sharing Access Criteria
Data are available for 5 years at a third party website (Open Science Framework: https://osf.io/).
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.